Single-center, Randomized, Double-blind, Placebo-controlled, Parallel-groups Study of Lubiprostone in Patients With Multiple Sclerosis-Associated Constipation.
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2015
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation; Multiple sclerosis
- Focus Therapeutic Use
- 09 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Dec 2010 New trial record